Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$NTRR OTCQB closed deal 1 of 2 deals https://www.otcmarkets.com/stock/NTRR/news
Looking good NTRR #30 on the Most Read Board
For those wondering what OTC QB is all about:
The OTCQB® Venture Market is for early-stage and developing U.S. and international companies. To be eligible, companies must be current in their reporting and undergo an annual verification and management certification process. Companies must meet $0.01 bid test and may not be in bankruptcy
Eligibility Requirements
- U.S. companies must have audited annual financials by a PCAOB auditor. (Tier 2 Regulation A Companies are exempt from requirement to use a PCAOB auditor for their initial audit)
- Meet minimum bid price test of $0.01
- Not be in bankruptcy
- Have at least 50 Beneficial Shareholders, each owning at least 100 shares
- Have a freely traded Public Float of at least 10% of the total issued and outstanding of that security.
Companies with a freely traded Public Float of at least 5% (and $2 million in market value of public float), or a separate class of securities traded on a national exchange may apply for an exemption (see OTCQB Standards)
- Have a transfer agent that participates in the Transfer Agent Verified Share Program
(US Companies only)
- International companies must be listed on a Qualified Foreign Exchange (or SEC Reporting) and submit a Letter of Introduction from an approved OTCQB Sponsor
Reporting Requirements
Meet one of the following Reporting Standards:
- SEC Reporting Standard
- Regulation A Reporting Standard (Tier 2)
- U.S. Bank Reporting Standard
- International Reporting Standard
- Alternative Reporting Standard
Timely disclosure of material news
Corporate Governance Requirements (Alternative Reporting only)
- Have a board of directors that includes at least two Independent Directors
- Have an Audit Committee, a majority of the members of which are Independent Directors
Verification Requirements
- Maintain a Verified Company Profile
- Post initial and annual verification and management certification
I am right there with you CrazyKar. This is exciting to watch
Do not forget Texas Gov. Greg Abbott just signed a hemp law that adds the nation’s second-largest state to the list of commercial hemp farming.
Neutra Corp and Vivis are Texas based CBD companies
$$NTRR$$
Listen to the interview with Sydney Jim
http://nnw.fm/VAHk9
$$NTRR$$
Latest Move Towards Acquisition Gives Neutra Corp. a Strong Retail Brand Identity in Booming Hemp CBD Market
Sugar Land, TX, July 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neutra Corp. (NTRR) is continuing its recent run of growth and expansion, this time inking an important letter of intent (LOI) with Vivis, an emerging retail brand of hemp-based health and nutritional products.
“This acquisition will give Neutra Corp. an even stronger market presence with an established brand already recognized for superiority,” said President Sydney Jim. “Vivis’ hemp-derived CBD (cannabidiol) products are third-party certified as containment-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With Vivis as the new retail face of Neutra, we’re expecting greater interest in the other products we’re bringing to market.”
The past eight months have seen Neutra Corp. make steady strides in its ongoing bid to capture market share in the rapidly growing hemp-derived CBD market. The respected Hemp Business Journal has predicted sales of hemp-based products could reach $22 billion within three years. In comparison, the same market posted sales of $390 million last year, the publication reported.
Our Chief Executive Officer and Principal Stockholder, Sydney Jim is one of the founders of VIVIS. Neutra Corp. will be able to acquire VIVIS at a discount to relative market value.
CBD is a natural, multi-purpose hemp extracted compound that offers a wide range of health and wellness benefits. Users report relief from anxiety, lessening the effects of seizures, slowing of neurodegenerative disorders, pain relief, and alleviation of certain cancer treatment side effects.
NOTICE REGARDING FORWARD LOOKING STATEMENT
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.
Neutra Corp. (OTCBB: NTRR) is an early-stage research and development company that’s bringing modern healthy living solutions to a multi-billion dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture—one where consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving Hemp-based CBD market, in which we intend to participate.
Sydney Jim
888-433-4033
info@neutrainc.com
Source: Neutra Corp.
© 2019 GlobeNewswire, Inc.
Number 1 on the BOB!!!!
Currently $0.0033 and a volume of 35,795,978.... Well above the average volume. Getting some nice attention
What is PAUL's problem?
Looking good, very thin ask
CBD is booming. But US farmers struggle to keep up with demand for industrial hemp
Neutra Corp is positioning itself for this booming business. Vertically aligning themselves with established retailer. Netura Corp acquired VIVIS a source for all hemp-based health and nutritional products. Netura Corp. is also acquiring J3 for the farming and warehousing.
It’s Hollywood’s new favorite beauty product. It’s the superfood du jour. Demand for CBD is so strong that companies are scrambling to infuse their products with it, but the CBD they’re finding isn’t all that great.
Congress legalized industrial hemp in December. With it, they also legalized hemp-derived CBD, short for cannabidiol, a cannabis compound that supposedly delivers the calming effects of marijuana without the high from THC.
Last year, retail sales of CBD consumer products in the U.S. were estimated at between $600 million and $2 billion, according to investment research firm Cowen. The bank conservatively forecasts sales to reach $16 billion by 2025, with health and wellness products leading the way and food, beverage, beauty and vapor to also play a role.
Legal hemp production, CBD products in Texas
On June 6, 2019 Gov. Greg Abbott signs law legalizing hemp production, CBD products in Texas The bipartisan law legalizing hemp and low-THC CBD products went into effect immediately.
Updated at 11:44 a.m. with a statement from Texans for Responsible Marijuana Policy Director Heather Fazio and at 1:50 p.m. with comment from Texas Commissioner of Agriculture Sid Miller.
AUSTIN — Gov. Greg Abbott signed a new law Monday that clears up which CBD products are legal in Texas and will also allow local farmers to grow hemp as a crop.
The law, which received bipartisan support in the state Legislature, goes into effect immediately.
It will allow Texas to set up a federally approved program for farmers to grow hemp as an industrial crop, including procedures for sampling, inspection and testing. It also expands the kind of hemp products that can be legally purchased in Texas to include any hemp or hemp-derived products containing less than 0.3 percent of THC, or tetrahydrocannabinol, the psychoactive compound found in cannabis plants.
This includes cannabidiol, or CBD, products. While Texans have found oils, tinctures and other CBD goods on store shelves for years, those that contained even trace amounts of THC were technically illegal here. Now, as long as these products are derived from hemp, contain less than 0.3 percent THC and meet other labeling and quality standards, they are legal.
https://www.dallasnews.com/news/politics/2019/06/11/gov-greg-abbott-signs-law-legalizing-hemp-production-cbd-products-in-texas/
Comparing O/S of $DCGD with $NTRR
Discovery Gold Corp (DCGD)
Authorized Shares 250,000,000 as of 08/07/2019
Outstanding Shares 249,777,311 as of 08/07/2019
Restricted 213,332,011 as of 08/07/2019
Unrestricted 36,445,300 as of 08/07/2019
Neutra Corp. (NTRR)
Authorized Shares 480,000,000 as of 08/05/2019
Outstanding Shares 191,218,778 as of 08/05/2019
Restricted 20,095,990 as of 08/05/2019
Unrestricted 171,122,788 as of 08/05/2019
VIVIS is your source for all hemp-based health and nutritional products. VIVIS was founded because of the need for high quality high potency hemp extracted goods. Medical grade hemp extract is revolutionary in the way we manage pain and anxiety. Whether the pain comes from diseases like Epilepsy, or high performance athletic injuries, and your everyday aches and pains, VIVIS makes its mission to help improve your quality of life with all our products.
The Global Wellness Institute reported last fall that the wellness industry grew by 6.4 percent each year from 2015 to 2017, topping $4.2 trillion as a market growing nearly twice as fast as the global economy (http://cnw.fm/Ljqn5) as a result of concerns over the rising costs of health care and growing reporting of select chronic ailments among younger-than-traditional populations. The global hemp industry is expected to experience a CAGR of 34 percent from now to 2025, according to Research and Markets analysts, growing from $4.6 billion to $26.6 billion (http://cnw.fm/aO1Qo).
Neutra Corp. Discusses Operations and Objectives in Exclusive NetworkNewsWire Audio Interview
Press Release | 08/29/2019
NEW YORK, Aug. 29, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio -- Neutra Corp. (OTCQB: NTRR) today announces the broadcast of its exclusive audio interview with NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community.
The interview can be heard at http://nnw.fm/VAHk9.
Neutra president and CEO Sydney Jim joins NNW’s Stuart Smith in an interview that discusses the company’s 2019 milestones, near-term goals and focus on vertical integration.
Jim starts with an overview of Neutra’s operations as a research and development company in the nutraceutical market, and why the company shifted its focus into the hemp-based cannabidiol (CBD) market.
Key to this transition is Jim’s background as a pro tennis player and competitive cyclist. After nearly 20 years of competing, his athletic history provides Neutra unique insight into how hemp-based CBD and nutraceuticals can help athletes manage their pain and compete with a high quality of life.
Neutra’s participation in the hemp-based CBD market is complementary to its broader goal of becoming a vertically integrated company engaged in cultivation, manufacturing, formulation of products, distribution and retail sales, Jim explains. This goal, too, has a competitive approach.
“Most of our focus, obviously, is in our quality and potency of our products, because there is a vast difference … between very cheap products and quality product,” he says, describing the company’s plans to infiltrate the market as a vertically integrated company.
The interview concludes with a look at Neutra’s goals for the remainder of 2019, including the completion of its strategic acquisition of Vivis.
About Neutra Corp.
Neutra Corp. (OTCBB: NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture—one where consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the company intends to participate. For more information, visit the company’s website at www.NeutraInc.com.
NOTE TO INVESTORS: The latest news and updates relating to NTRR are available in the company’s newsroom at http://nnw.fm/NTRR
About NetworkNewsAudio
NetworkNewsAudio (NNA) , a NetworkNewsWire (NNW) Solution, allows you to sit back and listen to market updates, CEO interviews and a Company AudioPressRelease (APR). These audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio (NNA) can assist your company by cutting through the overload of information in today's market, NNA brings its clients unparalleled visibility, recognition and brand awareness. NetworkNewsWire (NNW) is where news, content and information converge. NetworkNewsWire (NNW) is a comprehensive provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW has the unparalleled ability to reach a wide audience of investors, consumers, journalists and the general public with an ever-growing distribution network of more than 5,000 key syndication outlets across the nation.
For more information, visit: www.NetworkNewsAudio.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer.
Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.
Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com
This has a lot of potential, I am about to listen to the interview from 8/29/19.
The interview can be heard at http://nnw.fm/VAHk9
NTRR Neutra Corp.
OTCQB Member Since 03/2015
As of 8/5/2019
A/S 480,000,000
O/S 191,218,778
Restricted 20,095,990
Unrestricted 171,122,788
Held at DTC 157,758,550
Float 37,127,496 as of 06/11/2019
Neutra Corp. Completes Reverse Merger with Vivis a Hemp-Based Health and Nutritional Company
Posted: Sep 03, 2019 9:36 AM EDT
Sugar Land, TX – September 3, 2019 – GLOBE NEWSWIRE via NEWSWIRE – Neutra Corp. (NTRR) is continuing its recent run of growth and expansion, this time inking a reverse merger with Vivis, an emerging retail brand of hemp-based health and nutritional products.
“This reverse merger will give Neutra Corp. an even stronger market presence with an established brand already recognized for superiority,” said President Sydney Jim. “Vivis’ hemp-derived CBD (cannabidiol) products are third-party certified as containment-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With Vivis as the new retail face of Neutra, we’re expecting greater interest in the other products we’re bringing to market.”
The past eight months have seen Neutra Corp. make steady strides in its ongoing bid to capture market share in the rapidly growing hemp-derived CBD market. The respected Hemp Business Journal has predicted sales of hemp-based products could reach $22 billion within three years. In comparison, the same market posted sales of $390 million last year, the publication reported.
Our Chief Executive Officer and Principal Stockholder, Sydney Jim is one of the founders of VIVIS. Neutra Corp.
CBD is a natural, multi-purpose hemp extracted compound that offers a wide range of health and wellness benefits. Users report relief from anxiety, lessening the effects of seizures, slowing of neurodegenerative disorders, pain relief, and alleviation of certain cancer treatment side effects.
NOTICE REGARDING FORWARD LOOKING STATEMENT
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.
Neutra Corp. (OTCBB: NTRR) is an early-stage research and development company that’s bringing modern healthy living solutions to a multi-billion dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture—one where consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving Hemp-based CBD market, in which we intend to participate.
Sydney Jim
888-433-4033
info@neutrainc.com
Media Contact
Company Name: Neutra Corp.
Contact Person: Sydney Jim
Email: Send Email
Phone: 888-433-4033
Country: United States
Website: http://www.neutrainc.com/
Neutra Corp. Completes Reverse Merger with Vivis a Hemp-Based Health and Nutritional Company
Posted: Sep 03, 2019 9:36 AM EDT
Sugar Land, TX – September 3, 2019 – GLOBE NEWSWIRE via NEWSWIRE – Neutra Corp. (NTRR) is continuing its recent run of growth and expansion, this time inking a reverse merger with Vivis, an emerging retail brand of hemp-based health and nutritional products.
“This reverse merger will give Neutra Corp. an even stronger market presence with an established brand already recognized for superiority,” said President Sydney Jim. “Vivis’ hemp-derived CBD (cannabidiol) products are third-party certified as containment-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With Vivis as the new retail face of Neutra, we’re expecting greater interest in the other products we’re bringing to market.”
The past eight months have seen Neutra Corp. make steady strides in its ongoing bid to capture market share in the rapidly growing hemp-derived CBD market. The respected Hemp Business Journal has predicted sales of hemp-based products could reach $22 billion within three years. In comparison, the same market posted sales of $390 million last year, the publication reported.
Our Chief Executive Officer and Principal Stockholder, Sydney Jim is one of the founders of VIVIS. Neutra Corp.
CBD is a natural, multi-purpose hemp extracted compound that offers a wide range of health and wellness benefits. Users report relief from anxiety, lessening the effects of seizures, slowing of neurodegenerative disorders, pain relief, and alleviation of certain cancer treatment side effects.
NOTICE REGARDING FORWARD LOOKING STATEMENT
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.
Neutra Corp. (OTCBB: NTRR) is an early-stage research and development company that’s bringing modern healthy living solutions to a multi-billion dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture—one where consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving Hemp-based CBD market, in which we intend to participate.
Sydney Jim
888-433-4033
info@neutrainc.com
Media Contact
Company Name: Neutra Corp.
Contact Person: Sydney Jim
Email: Send Email
Phone: 888-433-4033
Country: United States
Website: http://www.neutrainc.com/
Neutra Corp. Completes Reverse Merger with Vivis a Hemp-Based Health and Nutritional Company
Posted: Sep 03, 2019 9:36 AM EDT
Sugar Land, TX – September 3, 2019 – GLOBE NEWSWIRE via NEWSWIRE – Neutra Corp. (NTRR) is continuing its recent run of growth and expansion, this time inking a reverse merger with Vivis, an emerging retail brand of hemp-based health and nutritional products.
“This reverse merger will give Neutra Corp. an even stronger market presence with an established brand already recognized for superiority,” said President Sydney Jim. “Vivis’ hemp-derived CBD (cannabidiol) products are third-party certified as containment-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With Vivis as the new retail face of Neutra, we’re expecting greater interest in the other products we’re bringing to market.”
The past eight months have seen Neutra Corp. make steady strides in its ongoing bid to capture market share in the rapidly growing hemp-derived CBD market. The respected Hemp Business Journal has predicted sales of hemp-based products could reach $22 billion within three years. In comparison, the same market posted sales of $390 million last year, the publication reported.
Our Chief Executive Officer and Principal Stockholder, Sydney Jim is one of the founders of VIVIS. Neutra Corp.
CBD is a natural, multi-purpose hemp extracted compound that offers a wide range of health and wellness benefits. Users report relief from anxiety, lessening the effects of seizures, slowing of neurodegenerative disorders, pain relief, and alleviation of certain cancer treatment side effects.
NOTICE REGARDING FORWARD LOOKING STATEMENT
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.
Neutra Corp. (OTCBB: NTRR) is an early-stage research and development company that’s bringing modern healthy living solutions to a multi-billion dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture—one where consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving Hemp-based CBD market, in which we intend to participate.
Sydney Jim
888-433-4033
info@neutrainc.com
Media Contact
Company Name: Neutra Corp.
Contact Person: Sydney Jim
Email: Send Email
Phone: 888-433-4033
Country: United States
Website: http://www.neutrainc.com/
Adimarket Set to Share Innovative Exosomes Products at Upcoming Medical Congresses
The online retailer launched its new line of products in July and will speak with physicians seeking new treatment products and protocols to alleviate patient suffering
MIAMI LAKES, Florida—Adimarket, LLC, an online marketplace for regenerative medicine practitioners and a subsidiary of the Global Stem Cells Group (GSCG), has taken to the road in a series of business trips with the intent of promoting the group’s new line of exosomes, a neonatal-derived stem cells product.
The exosomes products were launched in July 2019 in Buenos Aires, and during the weekend of August 23, Adimarket representatives were in Santiago de Chile to sponsor one of the regenerative medicine industry’s most prolific medical congresses, hosted by the Chilean Society of Aesthetic Surgery. During the event, Mr. Benito Novas, Chief Executive Officer of the Global Stem Cells Group, was on hand to officially launch the exosomes products with a lecture in the congress’ main room.
The Adimarket and GSCG teams will continue their series of business trips to introduce Adimarket’s line of exosomes products to physicians across the globe. Currently, two additional business trips are on the docket where representatives will attend two upcoming medical congresses.
On September 25, 2019 GSCG faculty members will attend the 4th International Congress of Aesthetic Gynecology in Veracruz, Mexico to be held at the Holiday Inn Hotel. One faculty member will speak to the audience about the newest exosomes products and their clinical applications.
The GSCG will also be hosting the International Cell Therapy Symposium on the University of Miami campus in Miami, Florida on October 24, 2019. The event is expected to draw a large attendance of physicians in the regenerative medicine field, and the GSCG has invited more than 10 scientists and practitioners with vast experience in regenerative medicine to host the congress’ educational sessions. At least five of the conference sessions will focus on how exosomes can help people suffering from degenerative diseases
“Adimarket, in conjunction with the Global Stem Cells Group, is pleased to be able to share its newest exosomes products with physicians across the globe practicing regenerative medicine,” said Benito Novas, CEO of the Global Stem Cells Group. “Our goal is to create groundbreaking products and treatment protocols that help physicians deliver innovative treatment options to their patients, helping to alleviate suffering caused by degenerative diseases.”
To learn more about Adimarket and its product offerings, visit https://www.adimarket.net/. To learn more about the Global Stem Cells Group and its efforts in the field of regenerative medicine, visit http://www.stemcellsgroup.com/.
http://www.stemcellsgroup.com/adimarket-exosomes-at-upcoming-medical-congresses/
Long LAHO,
~Magnus
Oh, thank you for checking and providing what is available.
Thank you and long UOIP
Magnus
Looks like another one talked into reality
Evilbean posted:
Pacer update:
Thursday, August 29, 2019
439 misc Letter Thu 5:30 PM
Letter to The Honorable Richard G. Andrews from Jennifer Ying regarding Response to Plaintiff's IPR Status Report - re438 Status Report. (Ying, Jennifer
Long UOIP,
~Magnus
Your content is always refreshing. LAHO/GSCG is a force to be reckoned with!!
Long LAHO,
~Magnus
ISSCA Set to Welcome 13 Speakers at Upcoming Symposium in Miami.
The International Society for Stem Cell Application (ISSCA) has announced its lineup of speakers for its upcoming Regenerative Medicine Symposium. The symposium will be held on the University of Miami campus in the Donna...
Tuesday, August 27th 2019, 3:33 PM EDT
The regenerative medicine symposium will be held on the University of Miami campus on October 24, 2019
(PRUnderground) August 27th, 2019
https://www.nbc29.com/story/40970138/issca-set-to-welcome-13-speakers-at-upcoming-symposium-in-miami
The International Society for Stem Cell Application (ISSCA) has announced its lineup of speakers for its upcoming Regenerative Medicine Symposium. The symposium will be held on the University of Miami campus in the Donna E. Shalala Student Center on October 24, 2019 and features an impressive lineup of global authorities in regenerative medicine.
ISSCA is a global leader in stem cells research, applications, and education, partnering with major global institutions and locations worldwide to host its independent medical congresses. This year’s symposium hosted on the University of Miami campus will feature industry experts from seven countries, including Spain, Argentina, Bolivia, Colombia, Ecuador, Mexico, and the US. Some notable speakers include the following:
Dra. Silvina Pastrana from Argentina, who serves as the Medical Director of the Stem Cells Center Buenos Aires. Dra. Pastrana will discuss her experiences in treating patients who suffer from osteoarthritis conditions.
Dr. Pedro Sanchez hails from Colombia and is a highly regarded regenerative medicine and orthopedic specialist. He currently practices in Bogota where he offers stem cells treatments for people who suffer from orthopedic conditions.
Dr. Miguel Guillermo Garbe of Spain serves as the president of the country’s Regenerative Medicine Association. He currently leads a seminal investigation on how to increase cardiological function in patients who have suffered from strokes.
Dr. Roberto Blum from Ecuador has worked in the stem cells field for over 10 years and will share his industry experience with attendees.
Dr. Victor Pereyra, an Argentinian neurosurgeon, will lecture on how ozone therapy and stem cells could help patients suffering from spinal injuries.
“The ISSCA is pleased to host this year’s symposium on the University of Miami campus and welcome such a notable slate of speakers,” said Benito Novas, ISSCA VP of Public Relations. “The symposium will provide an informative day where physicians can learn from global leaders in the stem cells industry with the hopes of bringing new knowledge and treatment options back to their practices for their patients suffering from degenerative diseases.”
To learn more about the ISSCA and its Miami symposium, visit
http://www.stemcellsgroup.com/.
About International Society for Stem Cells Applications
The International Society for Stem Cells Applications (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
ISSCA bridges the gaps between scientists and practitioners in Regenerative Medicine. Their code of ethics emphasizes principles of morals and ethical conducts.
At ISSCA, their vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification. ISSCA serves its members through advancements made to the specialty of regenerative medicine. They aim to encourage more physicians to practice regenerative
medicine and make it available to benefit patients both nationally and globally.
For more information, please visit https://www.issca.us/ or send an email to info@stemcellsgroup.com
Press Contact
Name: Benito Novas
Phone: +1 305 560 5337
Email: info@stemcellsgroup.com
Website: https://www.issca.us/
Not every helpful association is immediately recognized. For example MADD Mothers Against Drunk Driving.
Per "https://en.wikipedia.org/wiki/Mothers_Against_Drunk_Driving"
"On May 3, 1980, Cari Lightner, a 13-year-old girl, was killed by a drunken hit-and-run driver at Sunset and New York Avenues in Fair Oaks, California. The 46-year-old driver, who had recently been arrested for another DUI hit-and-run, left Cari's body at the scene.[4] Cari's mother, Candace (Candy) Lightner, organized Mothers Against Drunk Driving and subsequently served as its founding president. A 1983 television movie about Lightner garnered publicity for the group, which grew rapidly."
You see, it took three years and a television movie to get MADD recognized.
Here is information about ISSCA,
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
About International Society for Stem Cells Applications
The International Society for Stem Cells Applications (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
ISSCA bridges the gaps between scientists and practitioners in Regenerative Medicine. Their code of ethics emphasizes principles of morals and ethical conducts.
At ISSCA, their vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification. ISSCA serves its members through advancements made to the specialty of regenerative medicine. They aim to encourage more physicians to practice regenerative
medicine and make it available to benefit patients both nationally and globally.
For more information, please visit https://www.issca.us/ or send an email to info@stemcellsgroup.com
Long LAHO,
~Magnus
Good message TT, I also believe big money controls the FDA
My hope is that quality medical treatment can be offered to everyone and sadly the FDA will hinder people from seeking stem cell treatment. I hope LAHO/GSCG brings this matter to the public.
Long LAHO,
~Magnus
This is great news
Long LAHO,
~Magnus
ISSCA Press Release
ISSCA Set to Welcome 13 Speakers at Upcoming Symposium in Miami.
Industry: Healthcare
The regenerative medicine symposium will be held on the University of Miami campus on October 24, 2019
Miami Lakes, FL (PRUnderground) August 27th, 2019
Tweet
Delicious
The International Society for Stem Cell Application (ISSCA) has announced its lineup of speakers for its upcoming Regenerative Medicine Symposium. The symposium will be held on the University of Miami campus in the Donna E. Shalala Student Center on October 24, 2019 and features an impressive lineup of global authorities in regenerative medicine.
ISSCA is a global leader in stem cells research, applications, and education, partnering with major global institutions and locations worldwide to host its independent medical congresses. This year’s symposium hosted on the University of Miami campus will feature industry experts from seven countries, including Spain, Argentina, Bolivia, Colombia, Ecuador, Mexico, and the US. Some notable speakers include the following:
· Dra. Silvina Pastrana from Argentina, who serves as the Medical Director of the Stem Cells Center Buenos Aires. Dra. Pastrana will discuss her experiences in treating patients who suffer from osteoarthritis conditions.
· Dr. Pedro Sanchez hails from Colombia and is a highly regarded regenerative medicine and orthopedic specialist. He currently practices in Bogota where he offers stem cells treatments for people who suffer from orthopedic conditions.
· Dr. Miguel Guillermo Garbe of Spain serves as the president of the country’s Regenerative Medicine Association. He currently leads a seminal investigation on how to increase cardiological function in patients who have suffered from strokes.
· Dr. Roberto Blum from Ecuador has worked in the stem cells field for over 10 years and will share his industry experience with attendees.
· Dr. Victor Pereyra, an Argentinian neurosurgeon, will lecture on how ozone therapy and stem cells could help patients suffering from spinal injuries.
“The ISSCA is pleased to host this year’s symposium on the University of Miami campus and welcome such a notable slate of speakers,” said Benito Novas, ISSCA VP of Public Relations. “The symposium will provide an informative day where physicians can learn from global leaders in the stem cells industry with the hopes of bringing new knowledge and treatment options back to their practices for their patients suffering from degenerative diseases.”
To learn more about the ISSCA and its Miami symposium, visit
http://www.stemcellsgroup.com/.
About International Society for Stem Cells Applications
The International Society for Stem Cells Applications (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
ISSCA bridges the gaps between scientists and practitioners in Regenerative Medicine. Their code of ethics emphasizes principles of morals and ethical conducts.
At ISSCA, their vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification. ISSCA serves its members through advancements made to the specialty of regenerative medicine. They aim to encourage more physicians to practice regenerative
medicine and make it available to benefit patients both nationally and globally.
For more information, please visit https://www.issca.us/ or send an email to info@stemcellsgroup.com
https://www.prunderground.com/issca-set-to-welcome-13-speakers-at-upcoming-symposium-in-miami/00164625/
Long LAHO,
~Magnus
Current Press Release
Global Stem Cells Group Meets Demands of Patients Seeking Stem Cells Treatment with New Facilities
Industry: Healthcare
The group’s new permanent office in Cancun will help streamline the patient experience by providing holistic support throughout the treatment process.
Miami Lakes, FL (PRUnderground) August 27th, 2019
The Global Stem Cells Group (GSCG) today announced that it will be opening a permanent office in Cancun, Mexico. The decision to expand its corporate presence into Cancun was based on the rising demand for patients seeking stem cells treatments at the group’s facilities already established in Cancun. The GSCG maintains two regenerative medicine operations in Cancun, which include medical facilities and a stem cells laboratory.
GSCG’s Cancun facilities provide state-of-the art options for patients seeking stem cells treatments that are currently not available in the US. While these protocols and products are currently unavailable within the US’s borders due to regulations, the Cancun center has still adopted the FDA’s frameworks for safe and effective regenerative medicine products and therapies. Guided by these protocols, physicians at the center deliver safe and effective stem cells therapies and products that can help patients suffering from degenerative diseases recover more quickly than with traditional treatment protocols.
With the establishment of a permanent office presence in Cancun, the GSCG seeks to provide a seamless holistic experience for patients seeking treatment at its facilities. With its office located near its medical center and laboratory, the GSCG team can more closely monitor the treatment process from the time the patient arrives at the Cancun airport to the time their treatment is complete and they return to the US.
“The Global Stem Cells Group is pleased to establish a permanent presence in Cancun with the opening of this new office location,” said Benito Novas, CEO of the Global Stem Cells Group. “By expanding our presence, we will be able to open up additional treatment opportunities for physicians in the US who may be limited by FDA regulations in ensuring their patients receive the critical stem cells therapies they need. US patients looking for relief from regenerative diseases are welcome at our Cancun center and will appreciate our state-of-the art facilities and top-notch care.”
To learn more about the Global Stem Cells Group and its latest efforts, visit http://www.stemcellsgroup.com/.
About Global Stem Cells Group
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
https://www.prunderground.com/global-stem-cells-group-meets-demands-of-patients-seeking-stem-cells-treatment-with-new-facilities/00164642/
Long LAHO,
~Magnus
Which are the best options For Treating Common Sports Injuries?
FRIDAY, 23 AUGUST 2019 / PUBLISHED IN BLOG
As physicians, we are constantly dealing with sports injuries. While they are typically not seen as life-threatening with high chances of recovery, they could potentially cause further problems down the line for the patient. Sports injuries can also take months to heal and getting patients back on their feet can take a lot of time, effort and money, which can be frustrating for patients who want to get back to playing football every weekend or for those who have a skiing holiday booked in the next month.
Recently, there has been a massive surge in the use of stem cells as an alternative treatment to common sports injuries. This article aims to outline the benefits and risks attached to using stem cells and how this alternative treatment may help patients who are suffering from common sports injuries.
....
https://www.stemcelltraining.net/best-options-for-treating-common-sports-injuries/
Long LAHO,
~Magnus
Thanks BrokeAgent
I didn't think before I asked, and many people bought in at the triple zeros. Still curious about what approx percentage a public company receives after everyone's cut.
Long UOIP,
~Magnus
Yes, I am referring to the market cap $$$, were did it go?
Long UOIP,
~Magnug
Has anyone discussed what happens to the stock money?
1.6B x $0.015 = $24M
What money is left after OTC and transfer agent fees
Is it safe to assume the funds are in a UnifiedOnline account.
Just curious,
~Magnus
That's great!!!!!! LMAFO!!!
The FCC has a plethora of information regarding broadband and households with broadband
https://www.fcc.gov/general/national-broadband-plan
You can also find a little bit of information at
https://www.leichtmanresearch.com/2-4-million-added-broadband-in-2018/
2.4 Million Added Broadband in 2018
Net Broadband Adds were Fifteen Percent Higher than in 2017
Durham, NH — March 7, 2019 — Leichtman Research Group, Inc. (LRG) found that the largest cable and telephone providers in the U.S. – representing about 95% of the market – acquired about 2.4 million net additional broadband Internet subscribers in 2018, compared to a pro forma gain of about 2.1 million subscribers in 2017.
These top broadband providers now account for 98.2 million subscribers, with top cable companies having 64.3 million broadband subscribers
...
Long UOIP,
~Magnus
Thank you jbbb for that revelation, that sounds awesome.
Long UOIP,
~Magnus